Ontology highlight
ABSTRACT: Background and aims
HCV GT-3 has a more pronounced effect on hepatic steatosis and host lipids than other HCV genotypes and is proving less responsive to all oral interferon-free treatment with direct acting antiviral agents. As both HCV GT3 infection and NASH can result in steatosis and cirrhosis, we asked whether hepatic transcriptional profiles reflective of the host response to inflammation differed based on the etiology of injury.Methods
Hepatic gene expression was determined for 48 pre-selected genes known to be associated with hepatic interferon signaling and lipid metabolic pathways in treatment-naïve HCV GT-3 (n = 9) and NASH (n = 14) patients.Results
Genes with significantly higher expression in HCV included chemokines CXCL10, CXCL11 interferon IFNA2, inte
SUBMITTER: Shrivastava S
PROVIDER: S-EPMC9502028 | biostudies-literature | 2016 Nov
REPOSITORIES: biostudies-literature